Chimerix Announces Pricing of Initial Public Offering RESEARCH TRIANGLE PARK, N.C., April 11, 2013 (GLOBE NEWSWIRE) — Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, announced today...
Durata Therapeutics Closes Public Offering of Common Stock CHICAGO, April 17, 2013 (GLOBE NEWSWIRE) — Durata Therapeutics, Inc. (Nasdaq:DRTX) today announced the closing of its public offering of 8,222,500 shares of common stock at a public offering price of...
Treato Raises $14.5m from OrbiMed, New Leaf and Reed Elsevier Proceeds to Expedite Commercialization of Treato Pharma Offering and US Expansion, Bringing ‘Voice of the Patient’ to Healthcare Stakeholders Yehud, Israel – April 23, 2013 – Treato, the social...
Spine Wave Announces U.S. FDA’s 510K Clearance of the StaXx® IB System, an Intervertebral Body Fusion Device The StaXx® IB System expands the StaXx® product portfolio and offers the advantage of an Expandable Intervertebral Body Fusion Device with Bone Graft Chambers...
Concert Pharmaceuticals Announces Strategic Collaboration with Celgene Corporation to Develop Deuterium-Modified Compounds LEXINGTON, MA – May 6, 2013 – Concert Pharmaceuticals, Inc. today announced that it has entered into a strategic collaboration with Celgene...
Recent Comments